Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial

INTRODUCTION: COVID-19 induces venous, arterial and microvascular thrombosis, involving several pathophysiological processes. In patients with severe COVID-19 without macrovascular thrombosis, escalating into high-dose prophylactic anticoagulation (HD-PA) or therapeutic anticoagulation (TA) could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Labbe, Vincent, Contou, Damien, Heming, Nicholas, Megarbane, Bruno, Ait-Oufella, Hafid, Boissier, Florence, Carreira, Serge, Robert, Alexandre, Vivier, Emmanuel, Fejjal, Mohamed, Doyen, Denis, Monchi, Mehran, Preau, Sebastien, Noel-Savina, Elise, Souweine, Bertrand, Zucman, Noémie, Picos, Santiago Alberto, Dres, Martin, Juguet, William, Mariotte, Eric, Timsit, Jean-François, Turpin, Matthieu, Razazi, Keyvan, Gendreau, Ségolène, Baloul, Samia, Voiriot, Guillaume, Fartoukh, Muriel, Audureau, Etienne, Mekontso Dessap, Armand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044512/
https://www.ncbi.nlm.nih.gov/pubmed/35473740
http://dx.doi.org/10.1136/bmjopen-2021-059383

Ejemplares similares

Ejemplares similares